Humanigen Q3 FY21: revenue $1.0M; diluted EPS −$1.12

Key figures from this report

These are the numbers Humanigen reported for Q3 FY21, the quarter ended Sep 30, 2021, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$1.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income−$66.7MAgainst −$30.8M in Q3 FY2010-Q income statement, on EDGAR
3. Diluted EPS−$1.12No year-earlier figure tagged10-Q income statement, on EDGAR
4. Cash and cash equivalents$76.5M−16% from $91.4M in Q3 FY2010-Q balance sheet, on EDGAR
5. Cash from operations−$48.0MAgainst −$23.5M in Q3 FY2010-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters